Emerging role of exosome-mediated intercellular communication in vascular remodeling.
作者信息
Su Sheng-An, Xie Yao, Fu Zurong, Wang Yaping, Wang Jian-An, Xiang Meixiang
机构信息
Department of Cardiology, Cardiovascular Key Lab of Zhejiang Province, Second Affiliated Hospital, Zhejiang University College of Medicine, Hang Zhou, Zhejiang, P.R. China.
Cardiovascular Division, King's College London BHF Center, London, United Kingdom.
出版信息
Oncotarget. 2017 Apr 11;8(15):25700-25712. doi: 10.18632/oncotarget.14878.
Vascular remodeling refers to the alternations of function and structure in vasculature. A complex autocrine/paracrine set of cellular interaction is involved in vascular remodeling. Exosome, a newly identified natural nanocarrier and intercellular messenger, plays a pivotal role in regulating cell-to-cell communication. Exosome emerges as an important mediator in the process of vascular remodeling, showing the most prognostic and therapeutic potent in vascular diseases. Benefiting from exosomal trafficking, the vasculature can not only maintain its function and structure in physiological condition, but also adapt itself in pathological status. In this review, we will represent the roles of exosomes in angiogenesis, endothelial function and cardiac regeneration. In addition, greatly depending on the pathophysiological status of donor cells and peripheral micro-circumstance, the exosomal content could alter, which makes exosomes exhibit pleiotropic effects in vascular diseases. Hence, the diverse effects of exosomes in vascular diseases including atherosclerosis, neointima formation and vascular repair, primary hypertension, pulmonary artery hypertension, and aortic aneurysm will be discussed. Finally, the translational appliances targeting exosomes will be concluded by providing updated applications of engineered exosomes in clinic.
相似文献
Biomed Pharmacother. 2019-5-8
J Control Release. 2015-7-2
Int J Med Sci. 2016-2-1
DNA Cell Biol. 2017-3
Int J Biochem Cell Biol. 2010-10-16
Vascul Pharmacol. 2015-8
引用本文的文献
Signal Transduct Target Ther. 2024-11-29
Front Cardiovasc Med. 2024-6-4
Front Bioeng Biotechnol. 2024-1-19
Int J Mol Sci. 2023-11-11
ACS Pharmacol Transl Sci. 2023-7-3
本文引用的文献
Curr Opin Nephrol Hypertens. 2016-3
Am J Physiol Renal Physiol. 2016-2-1
Stem Cell Res Ther. 2015-9-3